Roche's Bid to Acquire Illumina Topped Readers' Interest in 2012 | GenomeWeb

NEW YORK (GenomeWeb News) – Roche's bid to acquire Illumina, which was ultimately unsuccessful in the early part of 2012, topped our list of most-viewed articles on GenomeWeb Daily News for the year.

A series of articles on Roche's pursuit and Illumina's efforts to fend off the hostile takeover bid claimed six of the top 10 most-viewed articles on GWDN for 2012:

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.